Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema

Cutis

Volumn 57, Issue 2 SUPPL., 1996, Pages 62-68

  Lebwohl, Mark ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; FLUTICASONE; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; ECZEMA; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; OINTMENT; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CHILD; DOUBLE-BLIND METHOD; DRUG TOLERANCE; ECZEMA; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OINTMENTS;

EID: 0030078082     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Glaxo Group Research Limited: Clinical Investigators' Manual. Fluticasone Propionate (CCI 18781) in Dermatological Application, October 1990.
2. Data on file, Glaxo Dermatology, Division of Glaxo Wellcome Inc.
3. Lehmann EL Rank tests for comparing two treatments. In: Nonparametrics: Statistical Methods Based on Ranks. San Francisco, Calif: Holden-Day Inc; 1975:chap 1.
4. Van Elteren PH. On the combination of independent two sample tests of Wilcoxon. Bull Inst Int Stat 1960;37:351-361.